Hong Kong’s E15VC closes third fund at over $60m to focus on global deep tech
Tuesday, December 06, 2022
(DealStreetAsia by Simran Vaswani) – Hong Kong-headquartered venture capital (VC) firm E15VC has closed its third fund at $60.75 million, which will focus on global deep-tech investments, according to a company announcement on Tuesday.
The fund, which has a 10-year life, is anchored by Hong Kong’s alternative investments firm, Sun Hung Kai (SHK) & Co, which invests in public markets, alternatives, and real assets, with HK$49 billion ($6.2 billion) in assets under management. The deal was arranged by Sun Hung Kai Capital Partners Limited, the fund management arm of SHK & Co.
Founded in 2017 by Philip Liang, an MIT graduate, E15VC is a deep-tech focused, stage-agnostic VC firm.
Its portfolio companies include mental health SaaS platform Frankie, software development company Celebrity Agent, medical equipment manufacturer Caeli Vascular, and edtech startup SAM Labs. It was also an investor in Auris Health, a surgical robotics company which was acquired by Johnson and Johnson in 2019.
